Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Sep 11, 2024 11:37am
96 Views
Post# 36218616

RE:RE:General Sentiment

RE:RE:General Sentiment
CADInvestor12 wrote: I think the micro biz play (Remidose) is him showing restraint/ discipline in deploying resources .. it's a low risk/ high upside move for MPL to determine what the upside is/ how quickly they can capitalize .. if it turns into a significant opp, then I would expect them to aggressively deploy resources to support.. while refreshing to see a disciplined approach by management (esp amongst other cannabis businesses), it is equally frustrating.. our strong balance sheet is mentioned frequently, so take a bit of a risk. Know what I mean?



What Remidose shows is that they're spending resources (time and likely G&A monies on consultants) looking for near dead fish that we don't need.  And in assessing those dead fish, we are wasting time and not focusing on the things that should be focused on.

The walking dead will still be there when we are actually ready and if they're not, they're not.  I don't think we need to carcass hunt or cry our eyes out if a failed business isn't there anymore for us.

I also don't think that Remidose has any real IP (patents and the like, although I could be wrong, the search function for that is horrible), so what exactly didn't we win with that one.

So sure, low risk stuff like Remidose is all well and good, but it takes time and money, both of which should be better applied to our current SKU and solution set. 
<< Previous
Bullboard Posts
Next >>